Intellectual Property India Publishes Patent Application for Recombinant Antigen Against Zika/Dengue Virus, And Vaccine Composition Thereof And Use Thereof

MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617086799 A) filed by Beijing Benewill Technology Development Co. , Ltd. on July 15, 2026, for Recombinant Antigen Against Zika/Dengue Virus, And Vaccine Composition Thereof And Use Thereof.

Inventors include Yan, Jinghua; and Huang, Qingrui.

The application for the patent was published on September 18, 2026, under issue no. 38/2026.

Abstract: A recombinant antigen against Zika/Dengue virus, and a vaccine composition thereof and the use thereof. The recombinant antigen is obtained by means of introducing a specific mutation into the FL fusion loop region and optionally the non-FL fusion loop region of the E protein of a wild-type Zika/dengue vir...